Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 21946.10 Crore) operating in Pharmaceuticals sector.
By ETMarkets.com | Updated:
Getty Images
Promoters held 63.92 per cent stake in the company as of March 31, 2020, while FIIs held 3.69 per cent, DIIs 12.65 per cent and public and others 19.73 per cent.
ICICI Direct has given a buy rating to Pfizer with a target price of Rs 5450. The share price moved up by 0.12 per cent from its previous close of Rs 4797.55. The stock’s last traded price is Rs 4803.20.
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 21946.10 Crore) operating in Pharmaceuticals sector.
Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 2030.49 Crore to Sales Value (97.54 % of Total Sales), Sale of services which contributed Rs 50.93 Crore to Sales Value (2.44 % of Total Sales) and Scrap which contributed Rs .08 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.
Financials For the quarter ended 30-06-2020, the company reported a Standalone sales of Rs 514.89 Crore, up 2.57 % from last quarter Sales of Rs 502.01 Crore and down -5.42 % from last year same quarter Sales of Rs 544.40 Crore. The Company reported net profit after tax of Rs 124.45 Crore in latest quarter. Investment Rationale The brokerage expects the stock to continue with its current momentum and head towards Rs 5450 levels as it is the 123.6% external retracement of the previous major correction (Rs 5170-3955) placed at Rs 5450 levels.
Promoter/FII Holdings Promoters held 63.92 per cent stake in the company as of March 31, 2020, while FIIs held 3.69 per cent, DIIs 12.65 per cent and public and others 19.73 per cent.
AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer share prices: Why are vaccine stocks down?
